MicroVision Reports Director, Officer Changes & Compensation

Ticker: MVIS · Form: 8-K · Filed: 2025-09-04T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, executive-appointments, filing

TL;DR

MicroVision's 8-K shows board/officer changes and compensation details, filed Sept 4.

AI Summary

MicroVision, Inc. filed an 8-K on September 4, 2025, reporting changes related to its board of directors and officers, including elections and appointments. The filing also covers compensatory arrangements for certain officers and includes financial statements and exhibits. The report date for the earliest event is September 2, 2025.

Why It Matters

Changes in board composition and executive appointments can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing primarily concerns corporate governance and executive appointments, which are standard disclosures and do not inherently indicate significant financial risk.

Key Players & Entities

FAQ

What specific changes were made to MicroVision's board of directors or officers?

The filing indicates elections and appointments of certain officers and directors, as well as changes related to the departure of directors or certain officers.

What is the significance of the 'Compensatory Arrangements of Certain Officers' item?

This item pertains to the disclosure of compensation plans and agreements for key executives within MicroVision, Inc.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this filing occurred on September 2, 2025.

What is MicroVision, Inc.'s state of incorporation and principal executive office location?

MicroVision, Inc. is incorporated in Delaware and its principal executive offices are located in Redmond, Washington.

What other items are covered in this 8-K filing besides director and officer changes?

This 8-K also includes disclosures related to Regulation FD and financial statements and exhibits.

Filing Stats: 1,267 words · 5 min read · ~4 pages · Grade level 10.9 · Accepted 2025-09-04 09:27:18

Key Financial Figures

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) September 2, 2025 MicroVision, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34170 91-1600822 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 18390 NE 68 th Street Redmond , Washington 98052 (Address of principal executive offices) (Zip code) (425) 936-6847 (Registrant's telephone number, including area code) Not Applicable (Former name or former address if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol(s) Name of each exchange on which registered Common stock, par value $0.001 per share MVIS The NASDAQ Stock Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Chief Executive Officer Transition On September 2, 2025, the Board of Directors (the "Board") of MicroVision, Inc. (the "Company") appointed Glen W. DeVos, the Company's current Chief Technology Officer, to be the Company's President and Chief Executive Officer and a member of the Company's Board as of September 30, 2025 (the "Effective Date"), taking the place of the Company's current President and Chief Executive Officer, Sumit Sharma, who will continue to serve in that role until the Effective Date. In connection with his appointment as President and Chief Executive Officer, the Company and Mr. DeVos have entered an employment agreement (the "2025 CEO Agreement"). T he 2025 CEO Agreement includes the following terms and conditions: (i) Mr. DeVos's base salary will be $530,000 per annum, as may be adjusted from time to time at the discretion of the Board; (ii) Mr. DeVos will be eligible for short-term incentive compensation, including equity compensation, which will be determined at the discretion of the Board; (iii) Mr. DeVos will participate in the Company's Key Executive Severance and Change in Control Plan at the highest benefit levels previously disclosed in the Company's Form 8-K filed June 10, 2024; and (iv) Mr. DeVos will participate in the benefits and programs generally available to other employees of the Company, including expense reimbursement, retirement, insurance and vacation. As of the Effective Date, and pursuant to the terms of the 2025 CEO Agreement, the Board approved a short-term incentive bonus opportunity of 100% of Mr. DeVos' base salary tied to achievement of certain company financial, team and individual business objectives pursuant to the terms of the 2025 Executive Bonus Plan for Mr. DeVos. Additionally, on the Effective Date, Mr. DeVos will receive a grant of 539,000 RSUs to account for the difference between the grant for his new role as Chief Executive Officer and his former role as Chief Technology Officer. These RSUs will vest on June 6, 2026, only upon satisfactory achievement of specified company financial objectives and individual business objectives. In 2026, the Board, in its discretion, expects to determine a long-term incentive equity structure for Mr. DeVos. There are no family relationships between Mr. DeVos and any Company director or executive officer, and there are no arrangements or understandings between Mr. DeVos and any other person pursuant to which he was appointed as Chief Executive Officer. Mr. DeVos is not a party to any current or proposed transaction with the Company for which disclosure is required under Item 404(a) of Regulation S-K. Mr. Sharma's removal as President and Chief Executive Officer as of the Effective Date constitutes an "involuntary termination" for purposes of

View on Read The Filing